SecBot SecBot
Institutional Cluster

SVRA

Savara Inc
BULLISH
Impact 5/10
Horizonweeks Processed3mo ago
Institutional cluster: 5 buyers, 0 sellers (bullish)
Actionable Insight ▲ Bullish

The cluster of active managers adding positions suggests growing confidence in Savara's pipeline catalysts. Monitor upcoming clinical trial results or regulatory updates as potential triggers. The lack of insider buying tempers conviction, but the unanimous buying direction is a positive signal.

DirectionBullish
Confidencemedium
Horizonweeks

How the stock moved after the report

BULLISH VIEWSTOCK BELOW ENTRY AT T+60
Entry
$5.73
T+0 close · Aug 9, 2026 · via day close
Latest settled
−17.10%
T+60 · $4.75
Vs SPY
−14.69%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Aug 10 $5.73entry
  2. T+1 · 3mo ago −2.79%α −2.47% · $5.57
  3. T+5 · 3mo ago −6.28%α −6.24% · $5.37
  4. T+20 · 2mo ago −3.49%α −2.58% · $5.53
  5. T+60 · 14d ago −17.10%α −14.69% · $4.75

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Five institutional investors, including Citigroup and Russell Investments Group, significantly increased their positions in Savara Inc (SVRA) during Q2 2026, with net buying of $1.9M. No sellers were reported, indicating growing institutional conviction in the company's pharmaceutical pipeline.

Key Financial Metrics

Direction
accumulating
Buy Value
$3.4M
Sell Value
$0.00
Net Flow
$1.9M

Institutional Positions

Net institutional flow: $1.9M

▲ Buyers (5)

InstitutionActionChangePosition ValueValue Δ
CitigroupDOUBLED+395.1%$985.0K$809.0K
State Of New Jersey Common Pension Fund DADD+26.2%$184.0K$55.0K
Walleye CapitalADD+27.5%$1.5M$467.0K
Russell Investments GroupDOUBLED+736.4%$556.0K$497.0K
Arizona State Retirement SystemADD+34%$157.0K$53.0K

Key Facts

  • 5 buyers, 0 sellers in Q2 2026 institutional cluster
  • Citigroup doubled its stake (+395% shares, value from $176K to $985K)
  • Russell Investments Group increased by 736% (value from $59K to $556K)
  • Walleye Capital added 27.5% (value from $1.1M to $1.5M)
  • Total net institutional buying: $1.9M
  • No insider open-market buying (confluence score 16/100, divergent)

Financial Impact

Institutions accumulated $1.9M in net new positions, with total current holdings of $3.4M. This represents a small fraction of SVRA's $1.2B market cap.

institutional ownershipfloat

Risk Factors

  • 13F filings have a 45-day lag; positions may have been unwound since quarter-end
  • Dollar amounts are small relative to market cap, limiting impact on float
  • No insider buying corroborates the institutional thesis

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
93% bullish (14 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 institutional 13F filing from SEC EDGAR.

DocumentAccession Number
INST-CLUSTER Data (Synthetic)inst-cluster-SVRA-2026-Q2

Track record

4 reports on SVRA

Performance horizon
Filters
  1. Nov 16, 2026today SC 13G Neutral 3/10 Entry $4.60 settles Feb 12
  2. Aug 9, 202614w ago Institutional Cluster Bullish 5/10 Viewing Entry $5.73 to $4.75 ▼ −17.10% −14.69% vs SPY
  3. Jun 11, 202622w ago Institutional Cluster Mixed 4/10 Entry $5.26 to $5.53 ▲ +5.13% +1.87% vs SPY
  4. Apr 24, 202629w ago DEFA14A Neutral 3/10 Entry $5.16 to $5.65 ▲ +9.50% +4.72% vs SPY
Showing 4 of 4

US Market Status

Market Closed · Opens in 6h 42m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Aug 9, 2026